An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
Clinical trial NCT06047080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06047080
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2027-10-01
- Enrollment
- 1130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.